EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatic Form of Dihydrolipoamide Dehydrogenase Deficiency ( DLDD ): Phenotypic Spectrum, Laboratory Findings, and Therapeutic Approaches in 52 Patients

Nicole Hammann iD, Christian Staufner iD, Lea Dewi Schlieben, Antal Dezsőfi-Gottl, René G Feichtinger iD, Johannes Häberle, Norman Junge, Vassiliki Konstantopoulou, Robert Kopajtich, Valérie McLin, Daisy Rymen, Christoph Slavetinsky und 7 weitere

Journal of Inherited Metabolic Disease · 2025

DOI: 10.1002/jimd.70035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Nicole Hammann und 18 weiteren Autor:innen. Beteiligte Einrichtung: Heidelberg University, Medical Faculty, University Hospital Heidelberg, Center for Child and Adolescent Medicine, Division of Pediatric Neurology and…. Hauptthemen laut MEDLINE: Dihydrolipoamide Dehydrogenase, Mitochondrial Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dietmar Hopp Foundation, Austrian Science Fund, Dietmar Hopp Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dihydrolipoamide dehydrogenase deficiency (MIM 246900/DLDD) is an autosomal recessive mitochondrial disease with three clinical subgroups. The hepatic form leads to recurrent metabolic decompensations often accompanied by elevated levels of liver transaminases (ELT) in blood, sometimes progressing to acute liver failure (ALF). Genetically, it is linked to the p.G229C variant in the DLD gene, which has been reported in the Ashkenazi Jewish and Arabic population. In this study, we analyzed phenotypic diversity, therapeutic management, and outcome in novel symptomatic individuals with hepatic DLDD identified by whole exome sequencing ( n = 7) in Central Europe as well as in previously reported cases ( n = 45). Fifty‐one of 52 DLDD patients carried the p.G229C variant (39 in a homozygous state). During decompensations, precipitated by febrile infectious disease or fasting, affected individuals presented with nausea, vomiting, abdominal pain, hepatomegaly, hypoglycemia, and lactic acidosis. In individuals homozygous for the p.G229C variant, neurologic manifestations were rare, whereas mild neurologic symptoms were found in individuals ( n = 8) carrying a different DLD variant in trans . During decompensation, levels of specific plasma amino acids like citrulline or branched‐chain amino acids, and urinary organic acids, like 2‐oxoglutaric acid, were frequently elevated. However, known biomarkers—with the exception of lactate—were not consistently elevated during these episodes and typically normal in the interval, highlighting the usefulness of early genetic testing in all children with unexplained ELT or ALF to reduce the time to diagnosis. While there exists consensus for rescue therapy with intravenous glucose during decompensations and maintenance therapy with riboflavin, therapies with thiamine and antioxidants (e.g., N‐acetylcysteine) were reported to be useful in single individuals with recurrent decompensations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dihydrolipoamide DehydrogenaseMitochondrial DiseasesHumansMaleFemaleChildChild, PreschoolPhenotypeInfantAdolescentLiverAcidosis, LacticLiver Failure, AcuteExome SequencingMutationMaple Syrup Urine Disease

Stichwörter der Autor:innen

DLDE3hepatic mitochondriopathymitochondrial diseasepediatric acute liver failure

Substanzen

Dihydrolipoamide Dehydrogenase

Autor:innen und Institutionen

  • Heidelberg University, Medical Faculty, University Hospital Heidelberg, Center for Child and Adolescent Medicine, Division of Pediatric Neurology and Metabolic Medicine, Heidelberg, Germany.
  • Institute of Human Genetics, School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • Institute of Human Genetics, Helmholtz Zentrum Munich, Neuherberg, Germany.
  • Bókay Street Department, Pediatric Centre, Semmelweis University, Budapest, Hungary.
  • University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.
  • University Children's Hospital Zurich and Children's Research Center, Zurich, Switzerland.

ORCID-Profile: Nicole Hammann, Christian Staufner, René G Feichtinger, Johannes A Mayr, Stefan Kölker, Georg F Hoffmann, Dominic Lenz

Förderung

  • Dietmar Hopp Foundation
  • Austrian Science Fund
  • Dietmar Hopp Stiftung

Zitieren

APA

Hammann, N., Staufner, C., Schlieben, L. D., Dezsőfi-Gottl, A., Feichtinger, R. G., Häberle, J., Junge, N., Konstantopoulou, V., Kopajtich, R., McLin, V., Rymen, D., Slavetinsky, C., Sturm, E., Mayr, J. A., Wagner, M., Kölker, S., Prokisch, H., Hoffmann, G. F., & Lenz, D. (2025). Hepatic Form of Dihydrolipoamide Dehydrogenase Deficiency ( DLDD ): Phenotypic Spectrum, Laboratory Findings, and Therapeutic Approaches in 52 Patients. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70035

Vancouver

Hammann N, Staufner C, Schlieben LD, Dezsőfi-Gottl A, Feichtinger RG, Häberle J, et al. Hepatic Form of Dihydrolipoamide Dehydrogenase Deficiency ( DLDD ): Phenotypic Spectrum, Laboratory Findings, and Therapeutic Approaches in 52 Patients. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70035

BibTeX
@article{Hammann2025,
  author = {Hammann, Nicole and Staufner, Christian and Schlieben, Lea Dewi and Dezsőfi-Gottl, Antal and Feichtinger, René G and Häberle, Johannes and Junge, Norman and Konstantopoulou, Vassiliki and Kopajtich, Robert and McLin, Valérie and Rymen, Daisy and Slavetinsky, Christoph and Sturm, Ekkehard and Mayr, Johannes A and Wagner, Matias and Kölker, Stefan and Prokisch, Holger and Hoffmann, Georg F and Lenz, Dominic},
  title = {Hepatic Form of Dihydrolipoamide Dehydrogenase Deficiency ( DLDD ): Phenotypic Spectrum, Laboratory Findings, and Therapeutic Approaches in 52 Patients},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  doi = {10.1002/jimd.70035}
}
Kostenlos starten →